Search

Your search keyword '"Rametta, Raffaela"' showing total 248 results

Search Constraints

Start Over You searched for: Author "Rametta, Raffaela" Remove constraint Author: "Rametta, Raffaela"
248 results on '"Rametta, Raffaela"'

Search Results

2. Prevalence and Risk Factors of Significant Fibrosis in Patients With Nonalcoholic Fatty Liver Without Steatohepatitis

3. PNPLA3 has retinyl-palmitate lipase activity in human hepatic stellate cells

5. MERTK rs4374383 polymorphism affects the severity of fibrosis in non-alcoholic fatty liver disease

6. The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids

7. Statin use and non-alcoholic steatohepatitis in at risk individuals

10. The rs2294918 E434K Variant Modulates Patatin-Like Phospholipase Domain-Containing 3 Expression and Liver Damage

11. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD

15. Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

16. PCSK9 rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD

18. Hepatic notch signaling correlates with insulin resistance and nonalcoholic fatty liver disease

19. PCSK9 rs11591147 R46L loss‐of‐function variant protects against liver damage in individuals with NAFLD

23. A polygenic risk score for progressive non-alcoholic fatty liver disease risk stratification

24. Validation of interleukin-32 as a new circulating fatty liver biomarker

27. Mboat7 down-regulation by hyper-insulinemia induces fat accumulation in hepatocytes

28. Liver transcriptomics highlights interleukin-32 as novel NAFLD-related cytokine and candidate biomarker

29. Impact of natural neuromedin‐B receptor variants on iron metabolism

32. The A736V TMPRSS6 polymorphism influences hepcidin and iron metabolism in chronic hemodialysis patients: TMPRSS6 and hepcidin in hemodialysis

33. The i148m Pnpla3 polymorphism influences serum adiponectin in patients with fatty liver and healthy controls

34. PCSK7 gene variation bridges atherogenic dyslipidemia with hepatic inflammation in NAFLD patients

35. LBP-32-The Natural History of Ferroportin Disease-First Results of the International, Multicenter EASL non-HFE Registry

38. PS-006-MBOAT7 downregulation induces hepatic lipid accumulation

39. SAT-275-Interleukin-32 as a novel NAFLD biomarker in PNPLA31148M variant carriers

40. MBOAT7 Down-Regulation by Hyperinsulinemia Induces Fat Accumulation in Hepatocytes

42. Lack of association between peroxisome proliferator-activated receptors alpha and gamma2 polymorphisms and progressive liver damage in patients with non-alcoholic fatty liver disease: a case control study

44. Protein phosphatase 1 regulatory subunit 3B gene variation protects against hepatic fat accumulation and fibrosis in individuals at high risk of nonalcoholic fatty liver disease

45. Insulin resistance promotes Lysyl Oxidase Like 2 induction and fibrosis accumulation in non-alcoholic fatty liver disease

47. Proprotein convertase 7 rs236918 associated with liver fibrosis in Italian patients with HFE‐related hemochromatosis

48. The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

49. Hepcidin resistance in dysmetabolic iron overload

Catalog

Books, media, physical & digital resources